France· FR:65808346
BRINEURA 150 mg, solution pour perfusion
A cerliponase alfa product containing cerliponase alfa, registered in France by BIOMARIN INTERNATIONAL LIMITED (IRLANDE). The same ATC class is registered in 10 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Cerliponase alfa is registered in 10 of 19 countries.
Countries holding a registration under ATC A16AB17 (cerliponase alfa), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Cerliponase alfa · ATC A16AB17
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CERLIPONASE ALFA
- Manufacturer
- BIOMARIN INTERNATIONAL LIMITED (IRLANDE)
- Country
- France (FR)
- ATC code
- A16AB17
- ATC class
- Cerliponase alfa
- Defined daily dose
- 21 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550337142 flacon(s) en verre de 5 ml - 1 flacon(s) en verre de 5 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cerliponase alfa in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBrineura 150 mgBioMarin International
- CzechiaBRINEURABioMarin International Limited, Dublin
- SpainBRINEURA 150 MG SOLUCION PARA PERFUSIONBiomarin International Limited
- FinlandBrineuraBiomarin International Limited
- IrelandBrineura 150 mg solution for infusionBioMarin International Limited
- IcelandBrineuraBioMarin International Limited
- NetherlandsBrineura 150 mg oplossing voor infusieBioMarin International Limited
- SwedenBrineura 150 mg Infusionsvätska, lösningBioMarin International Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Brineura
- Liechtenstein · Brineura
- Norway · Brineura
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1ab9c13-45f0-46d0-87d5-9b5088b5e19b GET /v1/drugs/d1ab9c13-45f0-46d0-87d5-9b5088b5e19b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65808346",
"date_amm": "2017-05-30",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/17/1192",
"substance": "CERLIPONASE ALFA",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution et solution pour perfusion",
"voies_administration": "intracérébroventriculaire",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about cerliponase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.